Gene Symbol | IL4R |
Entrez ID | 3566 |
Uniprot ID | P24394 |
Description | interleukin 4 receptor |
Chromosomal Location | chr16: 27,313,668-27,364,778 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0002532 |
production of molecular mediator involved in inflammatory response |
The synthesis or release of any molecular mediator of the inflammatory response following an inflammatory stimulus, resulting in an increase in its intracellular or extracellular levels. |
IEA |
BP |
GO:0002639 |
positive regulation of immunoglobulin production |
Any process that activates or increases the frequency, rate, or extent of immunoglobulin production. |
IEA |
BP |
GO:0006955 |
immune response |
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
TAS |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
TAS |
BP |
GO:0016064 |
immunoglobulin mediated immune response |
An immune response mediated by immunoglobulins, whether cell-bound or in solution. |
IEA |
BP |
GO:0030728 |
ovulation |
The release of a mature ovum/oocyte from an ovary. |
IEA |
BP |
GO:0035771 |
interleukin-4-mediated signaling pathway |
A series of molecular signals initiated by the binding of interleukin-4 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
IEA |
BP |
GO:0042127 |
regulation of cell proliferation |
Any process that modulates the frequency, rate or extent of cell proliferation. |
IEA |
BP |
GO:0042832 |
defense response to protozoan |
Reactions triggered in response to the presence of a protozoan that act to protect the cell or organism. |
IEA |
BP |
GO:0043032 |
positive regulation of macrophage activation |
Any process that stimulates, induces or increases the rate of macrophage activation. |
IEA |
BP |
GO:0043306 |
positive regulation of mast cell degranulation |
Any process that activates or increases the frequency, rate or extent of mast cell degranulation. |
IEA |
BP |
GO:0043627 |
response to estrogen |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics. |
IEA |
BP |
GO:0045626 |
negative regulation of T-helper 1 cell differentiation |
Any process that stops, prevents, or reduces the frequency, rate or extent of T-helper 1 cell differentiation. |
IEA |
BP |
GO:0045630 |
positive regulation of T-helper 2 cell differentiation |
Any process that activates or increases the frequency, rate or extent of T-helper 2 cell differentiation. |
IEA |
BP |
GO:0090197 |
positive regulation of chemokine secretion |
Any process that increases the rate, frequency or extent of chemokine secretion, the regulated release of chemokines from a cell. |
IEA |
BP |
GO:1901741 |
positive regulation of myoblast fusion |
Any process that activates or increases the frequency, rate or extent of myoblast fusion. |
IEA |
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IEA |
CC |
GO:0005887 |
integral component of plasma membrane |
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
TAS |
CC |
GO:0043235 |
receptor complex |
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
IDA |
MF |
GO:0004913 |
interleukin-4 receptor activity |
Combining with interleukin-4 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
TAS |
MF |
GO:0005057 |
receptor signaling protein activity |
Conveys a signal from an upstream receptor or intracellular signal transducer, converting the signal into a form where it can ultimately trigger a change in the state or activity of a cell. |
TAS |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
Domain ID | Description |
---|---|
IPR003531 |
Short hematopoietin receptor, family 1, conserved site |
IPR003961 |
Fibronectin type III |
IPR013783 |
Immunoglobulin-like fold |
IPR015319 |
Interleukin-4 receptor alpha, N-terminal |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04060 |
Cytokine-cytokine receptor interaction |
KEGG |
hsa04151 |
PI3K-Akt signaling pathway |
KEGG |
hsa04630 |
Jak-STAT signaling pathway |
KEGG |
hsa04640 |
Hematopoietic cell lineage |
KEGG |
hsa04658 |
Th1 and Th2 cell differentiation |
KEGG |
hsa04659 |
Th17 cell differentiation |
KEGG |
hsa05321 |
Inflammatory bowel disease (IBD) |
KEGG |
WP453 |
Inflammatory Response Pathway |
WikiPathways |
WP3932 |
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway |
WikiPathways |
WP395 |
IL-4 Signaling Pathway |
WikiPathways |
h_il4Pathway |
IL 4 signaling pathway |
BioCarta |
h_nktPathway |
Selective expression of chemokine receptors during T-cell polarization |
BioCarta |
h_th1th2Pathway |
Th1/Th2 Differentiation |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0007134 |
Renal Cell Carcinoma |
C0019693 |
HIV Infections |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
SOCS1 |
8651 |
O15524 |
0.00 |
SOCS2 |
8835 |
O14508 |
0.00 |
SOCS3 |
9021 |
O14543 |
0.00 |
SOCS7 |
30837 |
O14512 |
0.00 |
IRS1 |
3667 |
P35568 |
0.52 |
DOK2 |
9046 |
O60496 |
0.52 |
PRKCZ |
5590 |
Q05513 |
0.55 |
IL13 |
3596 |
P35225 |
0.62 |
ARIH2 |
10425 |
O95376 |
0.63 |
PIBF1 |
10464 |
Q8WXW3 |
0.63 |
KAT5 |
10524 |
Q92993 |
0.63 |
JAK2 |
3717 |
O60674 |
0.65 |
HGS |
9146 |
O14964 |
0.68 |
SOCS5 |
9655 |
O75159 |
0.70 |
IL4R |
3566 |
P24394 |
0.72 |
STAT6 |
6778 |
P42226 |
0.89 |
IL4 |
3565 |
P05112 |
0.90 |
FES |
2242 |
P07332 |
0.52 |
IRS2 |
8660 |
Q9Y4H2 |
0.52 |
MYC |
4609 |
P01106 |
0.63 |
ARHGEF3 |
50650 |
Q9NR81 |
0.63 |
CD40 |
958 |
P25942 |
0.67 |
NCF1 |
653361 |
P14598 |
0.73 |
JAK3 |
3718 |
P52333 |
0.75 |
INPP5D |
3635 |
Q92835 |
0.76 |
PTPN11 |
5781 |
Q06124 |
0.76 |
RACK1 |
10399 |
P63244 |
0.76 |
PTPN6 |
5777 |
P29350 |
0.86 |
IL13RA1 |
3597 |
P78552 |
0.88 |
JAK1 |
3716 |
P23458 |
0.88 |
SHC1 |
6464 |
P29353 |
0.88 |
IL2RG |
3561 |
P31785 |
0.90 |